Skip to Content

DF 7.5 (Darifenacin Hydrobromide Extended Release 7.5 mg)

Pill with imprint DF 7.5 is White, Round and has been identified as Darifenacin hydrobromide extended release 7.5 mg. It is supplied by Actavis Pharma, Inc..

Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DF 7.5

Darifenacin hydrobromide extended release

DF 7.5
7.5 mg
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.